Monitoring of the lung disorder caused by the treatment of everolimus for the TKI refractory advanced RCC.
Not Applicable
- Conditions
- renal cell carcinoma
- Registration Number
- JPRN-UMIN000004139
- Lead Sponsor
- Graduate school of Medicine, University of Kobe
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
everolimus hypersensitivity pregnant female
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation of the serum biomarkers and the findings of CT scan with early detection of pulmonary injury caused by everolimus.
- Secondary Outcome Measures
Name Time Method